Myasthenia gravis: vizsgálatok itt: Izrael

5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 2/3. fázisCsak meghívásos
  Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

  Where

  Jerusalem

  Életkor

  2 év to 18 év

  People

  12 worldwide

  Run by

  argenx

  See details and how to joinNCT05374590 · EU 2023-507379-23-00
• 3. fázisTaking people
  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Where

  Haifa, Tel Aviv

  Életkor

  18 év to 74 év

  People

  115 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT07217587 · EU 2025-521130-28-00
• 2/3. fázisTaking people
  A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

  Where

  Jerusalem, Petah Tikvah, Tel Aviv

  Életkor

  2 év to 17 év

  People

  12 worldwide

  Run by

  argenx

  See details and how to joinNCT06392386 · EU 2023-506159-12-00
• 1. fázisTaking people
  Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

  Where

  Jerusalem

  Életkor

  18 év to 80 év

  People

  120

  Run by

  Polina Stepensky

  See details and how to joinNCT07085676
• 4. fázisNot yet taking people in Izrael
  Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis

  Where

  Haifa

  Életkor

  18 év to 99 év

  People

  16

  Run by

  Rambam Health Care Campus

  See details and how to joinNCT06688253